Registro:

Referencias:

• Sandberg, A.A., Turc-Carel, C., The cytogenetics of solid tumors: Relation to diagnosis, classification and pathology (1987) Cancer, 59, pp. 387-395
• Mertens, F., Johansson, B., Hoglund, M., Mitelman, F., Chromosomal imbalance maps of malignant solid tumors: A cytogenetic survey of 3185 neoplasms (1997) Cancer Res, 57, pp. 2765-2780
• Gebhart, E., Bruderlein, S., Augustus, M., Siebert, E., Feldner, J., Schmidt, W., Cytogenetic studies on human breast carcinomas (1986) Breast Cancer Res Treat, 8, pp. 125-138
• Dutrillaux, B., Gerbault-Seureau, M., Remvikos, Y., Zafrani, B., Prieur, M., Breast cancer genetic evolution: I. data from cytogenetics and DNA content (1991) Breast Cancer Res Treat, 19, pp. 245-255
• Mitchell, E.L., Santibanez-Koref, M.F., 1p13 is the most frequently involved band in structural chromosomal rearrangements in human breast cancer (1990) Genes Chromosomes Cancer, 2, pp. 278-289
• Trent, J.M., Cytogenetic and molecular biologic alterations in human breast cancer: A review (1985) Breast Cancer Res Treat, 5, pp. 221-229
• Eiriksdottir, G., Johannesdottir, G., Ingvarsson, S., Bjornsdottir, I.B., Jonasson, J.G., Agnarsson, B.A., Hallgrimsson, J., Barkardottir, R.B., Mapping loss of heterozygosity at chromosome 13q: Loss at 13q12-q13 is associated with breast tumour progression and poor prognosis (1998) Eur J Cancer, 34, pp. 2076-2081
• Whang-Peng, J., Lee, E.C., Kao-Shan, C.S., Seibert, K., Lippman, M., Cytogenetic studies of human breast cancer lines: MCF-7 and derived variant sublines (1983) J Natl Cancer Inst, 71, pp. 687-695
• Truong, K., Guilly, M.N., Gerbault-Seureau, M., Malfoy, B., Vielh, P., Dutrillaux, B., Evidence for in vitro selection during cell culturing of breast cancer: Detection by flow and image cytometry (1999) Cancer Genet Cytogenet, 114, pp. 154-155
• Gazdar, A.F., Kurvari, V., Virmani, A., Gollahon, L., Sakaguchi, M., Westerfield, M., Kodagoda, D., Shay, J.W., Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer (1998) Int J Cancer, 78, pp. 766-774
• Spira, J., Trisomy of chromosome #13 in spontaneous mammary tumors of GR, C3H, and noninbred Swiss mice (1980) J Natl Cancer Inst, 65, p. 668
• Dofuku, R., Utakoji, T., Matsuzawa, A., Trisomy of chromosome No 13 in spontaneous mammary tumors of GR, C3H, and noninbred Swiss mice (1979) J Natl Cancer Inst, 63, pp. 651-656
• Dofuku, R., Matsuzawa, A., A possible endomitotic origin of trisomy of chromosome 13: Karyological implications for murine mammary tumorigenesis (1983) Anticancer Res, 3, pp. 17-34
• Dofuku, R., Sonnenberg, A., Hilgers, J., Role of the gene on trisomic and pentasomic chromosome 13 in murine mammary tumorigenesis (1993) Cancer Genet Cytogenet, 69, pp. 100-107
• Sluyser, M., Evers, P., Hilgers, J., Translocations involving chromosome 1 in hormone-independent GR mouse mammary tumors (1985) Cancer Lett, 27, pp. 207-213
• Alonso, D.F., Farias, E.F., Urtreger, A., Ladeda, V., Vidal, M.C., Bal, D.K.J., Characterization of F3II, a sarcomatoid mammary carcinoma cell line originated from a clonal subpopulation of a mouse adenocarcinoma (1996) J Surg Oncol, 62, pp. 288-297
• Cool, M., Jolicoeur, P., Elevated frequency of loss of heterozygosity in mammary tumors arising in mouse mammary tumor virus/neu transgenic mice (1999) Cancer Res, 59, pp. 2438-2444
• Sacco, M.G., Gribaldo, L., Barbieri, O., Turchi, G., Zucchi, I., Collotta, A., Bagnasco, L., Vezzoni, P., Establishment and characterization of a new mammary adenocarcinoma cell line derived from MMTV neu transgenic mice (1998) Breast Cancer Res Treat, 47, pp. 171-180
• Hirsch, K.S., Jones, C.D., Lindstrom, T.D., Stamm, N.B., Sutton, G.P., Taylor, H.M., Weaver, D.E., Discovery and development of a novel class of nonsteroidal aromatase inhibitors (1987) Steroids, 50, pp. 201-217
• Squartini, F., Pingitore, R., 1994): Tumours of the mammary gland (1994) Pathology of tumours in laboratory animals. Volume 2. Tumors of the mouse, pp. 47-100. , V. Turusov, & U. Mohr. Lyon, France: International Agency for Research on Cancer
• Aldaz, C.M., Liao, Q.Y., Paladugu, A., Rehm, S., Wang, H., Allelotypic and cytogenetic characterization of chemically induced mouse mammary tumors: High frequency of chromosome 4 loss of heterozygosity at advanced stages of progression (1996) Mol Carcinog, 17, pp. 126-133
• Lanari, C., Molinolo, A.A., Pasqualini, C.D., Induction of mammary adenocarcinomas by medroxyprogesterone acetate in BALB/c female mice (1986) Cancer Lett, 33, pp. 215-223
• Molinolo, A.A., Lanari, C., Charreau, E.H., Sanjuan, N., Pasqualini, C.D., Mouse mammary tumors induced by medroxyprogesterone acetate: Immunohistochemistry and hormonal receptors (1987) J Natl Cancer Inst, 79, pp. 1341-1350
• Lamb, C., Simian, M., Molinolo, A., Pazos, P., Lanari, C., Regulation of cell growth of a progestin-dependent murine mammary carcinoma in vitro: Progesterone receptor involvement in serum or growth factor-induced cell proliferation (1999) J Steroid Biochem Mol Biol, 70, pp. 133-142
• Kordon, E., Lanari, C., Molinolo, A.A., Elizalde, P.V., Charreau, E.H., Pasqualini, C.D., Estrogen inhibition of MPA-induced mouse mammary tumor transplants (1991) Int J Cancer, 49, pp. 900-905
• Dran, G., Luthy, I.A., Molinolo, A.A., Charreau, E.H., Pasqualini, C.D., Lanari, C., Effect of medroxyprogesterone acetate (MPA) and serum factors on cell proliferation in primary cultures of an MPA-induced mammary adenocarcinoma (1995) Breast Cancer Res Treat, 35, pp. 173-186
• Lanari, C., Luthy, I., Lamb, C.A., Fabris, V., Pagano, E., Helguero, L.A., Sanjuan, N., Molinolo, A.A., Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: In vivo and in vitro effects of estrogens and progestins (2001) Cancer Res, 61, pp. 293-302
• Pandis, N., Heim, S., Bardi, G., Limon, J., Mandahl, N., Mitelman, F., Improved technique for short-term culture and cytogenetic analysis of human breast cancer (1992) Genes Chromosomes Cancer, 5, pp. 14-20. , [Erratum: Genes Chromosomes Cancer 1992;5:410]
• Seabright, M., A rapid banding technique for human chromosomes (1971) Lancet, 2, pp. 971-972
• Sumner, A.T., A simple technique for demonstrating centromeric heterochromatin (1972) Exp Cell Res, 75, pp. 304-306
• Standard karyotype of the mouse, Mus musculus (1972) J Hered, 63, pp. 69-72
• Weaver, Z.A., McCormack, S.J., Liyanage, M., Du Manoir, S., Coleman, A., Schrock, E., Dickson, R.B., Ried, T., A recurring pattern of chromosomal aberrations in mammary gland tumors of MMTV-cmyc transgenic mice (1999) Genes Chromosomes Cancer, 25, pp. 251-260
• Dietrich, W.F., Radany, E.H., Smith, J.S., Bishop, J.M., Hanahan, D., Lander, E.S., Genome-wide search for loss of heterozygosity in transgenic mouse tumors reveals candidate tumor suppressor genes on chromosomes 9 and 16 (1994) Proc Natl Acad Sci USA, 91, pp. 9451-9455
• Elliott, B.E., Xu, W., Mudrik, K., Marshall, J., Vekemans, M., Holden, J.J., Karyotypic evolution of a murine mammary adenocarcinoma in vitro and during progression from primary to metastatic growth in vivo (1992) Genes Chromosomes Cancer, 4, pp. 281-289
• Bal, D.K.J., Puricelli, L.I., Vidal, M.C., De Lustig, E.S., Characterization of two murine mammary adenocarcinoma tumors with different metastatic ability (1983) J Exp Clin Cancer Res, 2, pp. 151-160
• Ning, G., Jurecic, V., Baldini, A., Xu, J., Structure and chromosomal locations of mouse steroid receptor coactivator gene family (1999) In Vitro Cell Dev Biol Anim, 35, pp. 481-486
• Xu, J., Qiu, Y., DeMayo, F.J., Tsai, S.Y., Tsai, M.J., O'Malley, B.W., Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene (1998) Science, 279, pp. 1922-1925
• Goepfert, T.M., McCarthy, M., Kittrell, F.S., Stephens, C., Ullrich, R.L., Brinkley, B.R., Medina, D., Progesterone facilitates chromosome instability (aneuploidy) in p53 null normal mammary epithelial cells (2000) FASEB J, 14, pp. 2221-2229
• Burholt, D.R., Shackney, S.E., Ketterer, D.M., Pollice, A.A., Smith, C.A., Brown, K.A., Giles, H.R., Schepart, B.S., Karyotypic evolution of a human undifferentiated large cell carcinoma of the lung in tissue culture (1989) Cancer Res, 49, pp. 3355-3361
• Tsutsui, T., Barrett, J.C., Neoplastic transformation of cultured mammalian cells by estrogens and estrogenlike chemicals (1997) Environ Health Perspect, 105, pp. 619-624
• Li, J.J., Gonzalez, A., Banerjee, S., Banerjee, S.K., Li, S.A., Estrogen carcinogenesis in the hamster kidney: Role of cytotoxicity and cell proliferation (1993) Environ Health Perspect, 101, pp. 259-264
• Banerjee, S.K., Banerjee, S., Li, S.A., Li, J.J., 1992): Cytogenetic changes in renal neoplasms and during estrogen-induced renal tumorigenesis in hamsters (1992) Hormonal carcinogenesis, pp. 247-250. , J.J. Li, S. Nandi, & S.A. Li. New York: Springer-Verlag
• Liehr, J.G., Is estradiol a genotoxic mutagenic carcinogen? (2000) Endocr Rev, 21, pp. 40-54
• Dickson, R.B., Lippman, M.E., Growth factors in breast cancer (1995) Endocr Rev, 16, pp. 559-589
• Ross, R.K., Paganini-Hill, A., Wan, P.C., Pike, M.C., Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin (2000) J Natl Cancer Inst, 92, pp. 328-332
• (1999) Hormonal Contraception and Postmenopausal Hormonal Therapy (2-9 June 1998), , Lyon, France: IARC Scientific Publications, World Health Organization
• Lovell, M.M., Coco, R., Chromosomal damage induced in human lymphocytes by medroxyprogesterone acetate treatment for precocious puberty (1984) Medicina (Buenos Aires), 44, pp. 163-166
• Prahalada, S., Carroad, E., Cukierski, M., Hendrickx, A.G., Embryotoxicity of a single dose of medroxyprogesterone acetate (MPA) and maternal serum MPA concentrations in cynomolgus monkey (Macaca fascicularis) (1985) Teratology, 32, pp. 421-432
• Murphy, D.S., Hoare, S.F., Going, J.J., Mallon, E.E., George, W.D., Kaye, S.B., Brown, R., Keith, W.N., Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis (1995) J Natl Cancer Inst, 87, pp. 1694-1704
• Simpson, J.F., Quan, D.E., Ho, J.P., Slovak, M.L., Genetic heterogeneity of primary and metastatic breast carcinoma defined by fluorescence in situ hybridization (1996) Am J Pathol, 149, pp. 751-758
• Afify, A., Bland, K.I., Mark, H.F., Fluorescent in situ hybridization assessment of chromosome 8 copy number in breast cancer (1996) Breast Cancer Res Treat, 38, pp. 201-208
• Roka, S., Fiegl, M., Zojer, N., Filipits, M., Schuster, R., Steiner, B., Jakesz, R., Drach, J., Aneuploidy of chromosome 8 as detected by interphase fluorescence in situ hybridization is a recurrent finding in primary and metastatic breast cancer (1998) Breast Cancer Res Treat, 48, pp. 125-133
• Farabegoli, F., Ceccarelli, C., Santini, D., Trere, D., Baldini, N., Taffurelli, M., Derenzini, M., Chromosome 1 aneusomy with 1p36 under-representation is related to histologic grade, DNA aneuploidy, high c-erb B-2 and loss of bcl-2 expression in ductal breast carcinoma (1996) Int J Cancer, 69, pp. 381-385

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------